IRISIN: A NEW MARKER OF SUBCLINICAL ATHEROSCLEROSIS, CARDIOVASCULAR RISK AND DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS? - Remuzgo-Martinez, S; Rueda-Gotor, J; Pulito-Cueto, V; Lopez-Mejias, R; Corrales, A; Lera-Gomez, L; Perez-Fernandez, R; Portilla, V; Gonzalez-Mazon, I; Blanco, R; Genre, F; Exposito, R; et al. (ANNALS OF THE RHEUMATIC DISEASES, 2022)